>>JENNIFER WAUGH: THIS MORNING WE’RE TALKING HEALTH WITH DOCTOR SCOTT ACKERMAN NEW
RESEARCH SHOWS MORE PEOPLE ARE
BEATING BREAST CANCER FOR 3
REASONS LOCAL ONCOLOGIST DOCTOR
SCOT ACKERMAN JOINS US THIS
MORNING, GOOD MORNING.
>> GOOD MORNING JEN GOOD TO
SEE YOU.
>>JENNIFER WAUGH: YOU AND
LIKEWISE SO LET’S BREAK DOWN
THESE TREATMENTS. THE FIRST
INVOLVES SOMETHING THAT YOU
REMIND OUR VIEWERS OF ALL THE
TIME IT’S ABOUT CATCHING
CANCER EARLY.
>> RATES OF BREAST CANCER IS
WE’VE SEEN A GREAT INCREASE IN
SURVIVABILITY OF BREAST CANCER
AS YOU SAID FOR 3 REASONS
NUMBER ONE. IT’S EARLY
DETECTION. WOMEN HAVE REALLY
EMBRACED MAMMOGRAPHY
AND THEN GETTING IN A REGULAR
BASES JUST THE PAST 10 YEARS.
THE PREVALENCE OF WOMEN GAIN
THEIR MAMMOGRAM AS
APPROPRIATELY ON AN ANNUAL
BASIS OVER THE AGE OF 40
HAS INCREASED THEIR PHYSICIANS
ARE ARE BEING TO ORDER IT
THERE’S MORE ACCESSIBILITY
THERE ARE STILL SOME
DISPARITIES IN DIFFERENT
POPULATIONS MEDICALLY
UNDERSERVED POPULATIONS HAVE
WORSE BREAST CANCER OUTCOMES
BECAUSE THERE’S STILL SOME
ACCESS ISSUES. IN GENERAL
ACCESS FOR MAMMOGRAPHY ACCESS
FOR BREAST
CANCER SCREENING AS INTEREST
HAS INCREASED TREMENDOUSLY OVER
THE
PAST DECADE.
>>JENNIFER WAUGH: SO SECOND IS
CHEMOTHERAPY WHICH HAVE ALSO
TALKED ABOUT PREVIOUSLY, BUT
YOU KNOW THAT WE CAN REALLY HAS
BECOME LESS HARMFUL HAS ENDED
OVER THE LAST
FEW YEARS.
>> SO WHAT’S INTERESTING ABOUT
CHEMOTHERAPY AND A STEM IT’S IN
THE IN THE IN THE THING OF
SYSTEMIC THEIR PURSUIT
CHEMOTHERAPY. MO FARAH P
IMMUNOTHERAPY THE FIRST THING
IS THAT WE’RE LEARNING HOW TO
TARGET BETTER LEARNING
WHICH WE REALLY NEEDED AND SO
WE’RE ABLE TO AVOID
CHEMOTHERAPY IN MANY WOMEN
BECAUSE WE’RE ABLE TO ANALYZE
THE GENETIC MAKEUP OF THE
BREAST CANCER AND SEE WHICH
WOMEN HAVE A HIGH RISK BREAST
CANCER. WE WERE THEY WOULD NEED
CHEMOTHERAPY AND WOMEN WHO USED
TO THINK WOULD NEED IF WE FIND
OUT THEY ACTUALLY HAVE A LOW
RISK OR LOW RISK BREAST CANCER,
AND THEY DON’T NEED
CHEMOTHERAPY. SO IN IDENTIFYING
WHO REALLY IS AND WHO DOESN’T
WE’RE ABLE TO SPARE A LOT OF
WOMEN, NEEDLESS CHEMOTHERAPY,
AND HUMID THERE BILL THOUGH
BRENT’S CANCER FROM RECURRING
ELSEWHERE. IT ALSO HAS OTHER
LONG-TERM SIDE EFFECTS WE WANT
TO AVOID
LONG-TERM SIDE EFFECTS SUCH AS
SECONDARY MALIGNANCIES
DAMAGE TO THE LUNGS DAMAGE, THE
HEART DAMAGE
THE KIDNEYS. THOSE ALL CAN BE
LONG-TERM SECUELA OF
CHEMOTHERAPY. SO WE’RE GETTING
MUCH BETTER AT IDENTIFYING WHO
NEEDS AN
WHO DOESN’T.
>>JENNIFER WAUGH: AND IT IS THE
REASON FOR THAT ALSO BECAUSE
INSTEAD OF CHEMOTHERAPY.
LOOK AT THE OPTIONS OF EITHER
CONVENTIONAL RADIATION OR EVEN
PROTON THERAPY.
SO.
>> CHEMOTHERAPY IS ONE THING HE
WOULD THERE
BE USED TO MINIMIZE THE RISK OF
THE CANCER COME POPPING UP
SOMEWHERE ELSE IN THE BODY.
WE USE RADIATION
TO LOWER THE RISK OF THE BREAST
CANCER COMING BACK WITHIN THE
BREAST. THE REVISION ALSO DOES
MINIMIZE THE RISK OF A POPPING
UP ELSEWHERE.
WOMEN ARE LIVING A LOT LONGER
AFTER HAVING A DIAGNOSIS OF
BREAST CANCER AND HAVING
TREATMENT FOR BREAST CANCER.
SO WE USE RADIATION AND WE RATE
THE BREAST AFTER LUMPECTOMY
WITH CONVENTIONAL RADIATION.
THE CONCERN HAS BEEN OVER
THE YEARS. THE DOSE OF
RADIATION TO THE HEART TO THE
LUNGS. AND WHAT THAT WILL MEAN
TO A WOMAN 1015
20 YEARS LATER. WE FOUND THAT
WITH PROTON THERAPY AND SO
THERE’S SOME NEW STUDIES HAVE
RECENTLY COME OUT
PROTON THERAPY FOR AFTER A
LUMPECTOMY IS ABLE TO READY THE
BREAST THE SAME WAY BUT
SIGNIFICANTLY REDUCE THE DOSE
OF RADIATION TO THE HEART OF
THE LAW. YOU CAN SEE IN THE
GRAPHIC HERE ON THE LEFT THE
PICTURES WITH CONVENTIONAL
RADIATION AND THOUGH THOSE
COLORS OUR ARE THOSE CLOUDS.
YOU SEE THERE THE HEART OF THE
LUNG DISEASE IS A SIGNIFICANT
AMOUNT OF RADIATION. THE
PICTURE ON THE RIGHT IS WITH
PROTON BEAM RADIATION, YOU SEE
THE PROTON. RADIATION
DOSE CLOUD IS VERY MUCH CAN
FORMAL AROUND THE BREAST AND
THE HEART IT’S VIRTUALLY NO
RADIATION GETS LESS THAN
ONE-TENTH THE MATTER EDITION.
IT WAS CONVENTIONAL NATION AND
THE DOSE THE LUNG IS
SIGNIFICANTLY LESS THIS
TRANSLATES TO LESS
CARDIAC TOXICITY LESS RISK OF
HEART ATTACKS LATER ON IN LIFE,
LESS RISK OF PALMER A DAMAGE
CHRONIC OBSTRUCTIVE PULMONARY
DISEASE. THINGS LIKE THAT THAT
COULD HAPPEN LATER ON IN LIFE.
SO WOMEN ARE LIVING LONGER
AND WHEN WE’RE LIVING A BETTER
LIFE OF A HIT INCREASE QUALITY
OF LIFE BECAUSE OF THE USE OF